Health Condition 1: K590- Constipation
Conditions
Interventions
Intervention1: Safoof-i-Banafsha: After identification and authentication of the drug, Banafsha(viola odorata) will be finely powdered, sieved with No.80 mesh, mixed with equal quantity of Khand (Misr
Sponsors
Luqman Unani Medical College Hospital and Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: 1.Participants of either sex in the age group equal or more than 21years. 2.Patients meeting the "Rome IV diagnostic criteria for functional constipation" were included The criteria included experiencing two or more of the following: a. Straining during at least 25% of defecations b. Lumpy or hard stool in at least 25% of defecation. c. Sensation of incomplete evacuation for at least 25% of defecations d. Sensation of anorectal obstruction/blockage for at least 25% of defecations e. Manual maneuvers to facilitate at least 25% of defecations (e.g., digital evacuation, support of the pelvic floor) f. Fewer than three defecations per week 3.Loose stools are rarely present without the use of laxatives.
Exclusion criteria
Exclusion criteria: Patients using laxative medication (past 3days) and/or those on medications known to cause constipation (such as opioid analgesics, antidepressants, anticonvulsants). Individuals with a known case of megacolon/megarectum and obstructive cause of constipation. Cases with known HIV/AIDS, cancer, etc. Those with a known hypersensitivity to the study drug or any of its ingredients. Pregnant and lactating females. Individuals with Diabetes Mellitus.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in sign and symptoms of Daimi Qabz (Chronic constipation) by 1.VAS (Visual Analogue Scale) Straining at defecation Lumpy or hard stools Sensation of incomplete evacuation Sensation of anorectal blockage 2.Freuency of Bowel movement per day (0 to 2point scale) 3.Likert’s scale for manual maneuver. Timepoint: At baseline and every follow up and after completion of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| PAC-QOL QuestionnaireTimepoint: At baseline and after completion of treatment | — |
Countries
India
Contacts
Public ContactDr Khan Ameer Kauser Khan
Luqman Unani Medical College Hospital And Research Centre
Outcome results
None listed